A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
מצבים רפואיים
Duchene Muscular Dystrophy
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Arkansas Children's Research Institute, Little Rock, Arkansas, United States
Contact: Principal Investigator (Aravindhan Veerapandiyan)Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Sarah Wright, DO)Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Bridget McGowan)Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Gerald Mastellone) · Gerald.mastellone@childrens.harvard.edu · 857-218-4677Contact: Principal Investigator (Partha Ghosh, MD)University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
Contact: Principal Investigator (Stephen Chrzanowski)Columbia University Medical Center, New York, New York, United States
Contact: Principal Investigator (Divya Jayaraman)Duke University / Lenox Baker Children's Hospital, Durham, North Carolina, United States
Contact: Principal Investigator (Natalie Katz, MD)Oregon Health and Science University, Portland, Oregon, United States
Contact: Principal Investigator (Erika Finanger, MD)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Macarena Racciatti) · macarena.racciatti@seattlechildrens.org · 206-995-6847Contact: Principal Investigator (Alicia Henriquez)